Tradestie Institutional Equity Comparison Engine

STTK vs COCP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

STTK Overall Edge

STTK Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shattuck Labs, Inc. Common Stock (STTK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, STTK trades at N/M Forward P/E with 0.0% operating margin (-66.6% YoY revenue) versus COCP at N/M Forward P/E and -3063.6% operating margin (+26.9% YoY). In options structure, STTK sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
STTK N/M vs COCP N/M Fwd P/E
Growth & Margin Winner STTK
Op Margin 0.0% vs -3063.6% ยท YoY -66.6% vs +26.9%
Momentum & Technical Winner STTK
1Y +147.8% vs -3.0% ยท 52W Pos 43% vs 19%
Options & Structure Winner STTK
BREAKDOWN (10th %ile IV) vs UNCLASSIFIED (N/A IV)
STTK NASDAQ
Shattuck Labs, Inc. Common Stock
Pharmaceutical Preparations
$4.56
-1.94% 1D
Market Cap $474.6M
1M Return -15.87%
1Y Return +147.83%
Forward P/E N/M
Unified AI Score
51.1 / 100 HOLD
Tech 48.0 Fund 58.0 Flow 63.0 Mom 60.0
COCP NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.00
+1.98% 1D
Market Cap $19.6M
1M Return -2.01%
1Y Return -2.96%
Forward P/E N/M
Unified AI Score
47.1 / 100 HOLD
Tech 51.0 Fund 48.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: STTK +147.83% COCP -2.96% Spread: +150.79 pp (STTK Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period STTK Revenue COCP Revenue STTK Op. Margin COCP Op. Margin Margin Edge
FY2011 N/A $10M N/A -30.6% COCP
FY2019 $10M $10M -253.5% -737.4% STTK
FY2020 $10M $0M -371.8% -476.0% STTK
FY2021 $30M N/A -150.8% N/A STTK
FY2022 $0M N/A -15848.0% N/A STTK
FY2023 $0M N/A -5549.6% N/A STTK
FY2024 $10M N/A -1408.3% N/A STTK
FY2025 $0M N/A -5150.8% N/A STTK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: STTK (5) vs COCP (2)
Institutional Metric STTK COCP Criterion Row Winner
Market Capitalization Scale $474.6M $19.6M Larger Scale STTK
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -66.6% +26.9% Higher Growth COCP
Operating Margin (TTM) Profitability 0.0% -3063.6% Higher Margin STTK
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -47.2% -311.7% Higher ROE STTK
52-Week Range Position Momentum 43% ($2โ€“$8) 19% ($1โ€“$2) Stronger Trend STTK
Beta / 30D Volatility Risk Regime 1.48ฮฒ ยท 78% Vol 1.04ฮฒ ยท 54% Vol Lower Realized Risk COCP
Unified Institutional Score Composite Signal 51.1 / 100 (HOLD) 47.1 / 100 (HOLD) Higher Composite STTK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full STTK vs COCP Buy Guide
STTK BREAKDOWN
58d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live STTK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
COCP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live COCP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither STTK nor COCP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.